Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Sequus' Amphotec earns 19th marketing approval

Jan. 10, 1997

Merck & Co. describes avermectin analogue

Jan. 10, 1997

Gilead files NDA for new cidofovir formulation

Jan. 7, 1997

Fujisawa reveals antibacterial series

Jan. 7, 1997

Kaken describes novel antibacterial agents

Jan. 7, 1997

Yale receives grant from Vion

Jan. 3, 1997

Novel cephalosporins reported by Japanese investigators

Jan. 3, 1997

Once-daily oral antibiotic from RPR cleared by FDA

Jan. 2, 1997

Mitotix reports antiviral/anticancer antisense constructs

Jan. 2, 1997

Bayer antibacterial cleared for wider use by FDA

Dec. 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...